Recent Finacing
Recent Raise
Pan Cancer T develops next-generation TCR-T cell therapies targeting solid tumours such as triple-negative breast cancer.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Pan Cancer.
